0001214659-21-009372.txt : 20210909 0001214659-21-009372.hdr.sgml : 20210909 20210909173239 ACCESSION NUMBER: 0001214659-21-009372 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210909 FILED AS OF DATE: 20210909 DATE AS OF CHANGE: 20210909 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: WITTE OWEN N. CENTRAL INDEX KEY: 0001700969 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38693 FILM NUMBER: 211245289 MAIL ADDRESS: STREET 1: C/O ALLOGENE THERAPEUTICS, INC. STREET 2: 210 EAST GRAND AVENUE CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Allogene Therapeutics, Inc. CENTRAL INDEX KEY: 0001737287 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 823562771 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 210 EAST GRAND AVENUE CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: (650) 457-2700 MAIL ADDRESS: STREET 1: 210 EAST GRAND AVENUE CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 4 1 marketforms-53760.xml PRIMARY DOCUMENT X0306 4 2021-09-09 0001737287 Allogene Therapeutics, Inc. ALLO 0001700969 WITTE OWEN N. 210 EAST GRAND AVENUE SOUTH SAN FRANCISCO CA 94080 true false false false Common Stock 2021-09-09 4 S false 5000 25.54 D 221182 D /s/ Veer Bhavnagri, Attorney-in-Fact 2021-09-09